Skip to main content

Nextel Medical Corp.

corporate_fare Company Profile

Nextel Medical Corp.

MAJI·OTC·Life Sciences·CIK 0001492448

Exousia Pro, Inc. is a clinical-stage biotechnology company focused on developing therapeutic applications of exosomes for oncology in the United States. The company was incorporated in 2010 and is based in Saint Petersburg, Florida. It was formerly known as Marijuana, Inc. and changed its name to Exousia Pro, Inc. in April 2025.

Nextel Medical Corp. (OTC:MAJI) is a publicly traded company in the Life Sciences sector. Wiseek monitors MAJI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • NexTel Medical Amends Acquisition to Buy Island 40 Group for $12.75M, Expanding Platform
  • Nextel Medical Amends Reg A Offering: Deep Discount $0.01 Share Price, Massive Dilution, and Increased Selling Shareholder Shares
  • Amended Regulation A Offering: Massive Dilution at Discounted Price to Fund Operations
  • Exousia Pro Amends Reg A Offering, Finalizes Pricing at $0.03/Share, and Settles Major Litigation
  • Exousia Pro Settles Litigation, Eliminating $200K Debt and Cancelling 6.3M Shares

Financial Snapshot

Fiscal year ended April 30, 2020
Revenue
$0
Net Income
-$435.95K
Op. Cash Flow
-$169.73K
Operating Income
-$467.86K
Cash & Equivalents
$0
Debt / Equity
0.00×
Shares Outstanding
249.84M sh
Source: 10-K · filed 2020-08-13 · accession 0001079973-20-000675

Dilution Risk

Low risk

Filing-implied dilution signals for MAJI, detected from its recent SEC filings · based on capital-structure filings through 2026-03-27.

Offering Price Slashed to $0.01 Per Share · Massive Potential Dilution from Offering

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

$0.0084
52-week range · as of 2026-03-27 $0.0084 – $0.3199
Market cap
$713.88K
Volume
2M (1.5× avg)
3-mo avg 1.3M
Live data · 2026-07-28 10:42 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed MAJI - Latest Insights

MAJI
Jul 22, 2026, 12:16 PM EDT
Source: GlobeNewswire
Importance Score:
7
NexTel Medical Amends Acquisition to Buy Island 40 Group for $12.75M, Expanding Platform
Price at Filing: $0.0084
Real-time Price: $0.0084 info
Change: $0 (0%) info
Market Cap: $713.882K info
Sentiment: Positive
View Wiseek Article
MAJI
Mar 27, 2026, 3:12 PM EDT
Filing Type: 253G1
Importance Score:
9
Nextel Medical Amends Reg A Offering: Deep Discount $0.01 Share Price, Massive Dilution, and Increased Selling Shareholder Shares
Price at Filing: $0.0429
Real-time Price: $0.0084 info
Change: -$0.0345 (-80%) info
Market Cap: $713.882K info
Sentiment: Negative
View Wiseek Article
MAJI
Mar 26, 2026, 4:25 PM EDT
Filing Type: 1-A POS
Importance Score:
9
Amended Regulation A Offering: Massive Dilution at Discounted Price to Fund Operations
Price at Filing: $0.044
Real-time Price: $0.0084 info
Change: -$0.0356 (-81%) info
Market Cap: $713.882K info
Sentiment: Negative
View Wiseek Article
MAJI
Mar 20, 2026, 4:23 PM EDT
Filing Type: 1-A POS
Importance Score:
9
Exousia Pro Amends Reg A Offering, Finalizes Pricing at $0.03/Share, and Settles Major Litigation
Price at Filing: $0.037
Real-time Price: $0.0084 info
Change: -$0.0286 (-77%) info
Market Cap: $713.882K info
Sentiment: Neutral
View Wiseek Article
MAJI
Mar 16, 2026, 10:15 AM EDT
Source: GlobeNewswire
Importance Score:
9
Exousia Pro Settles Litigation, Eliminating $200K Debt and Cancelling 6.3M Shares
Price at Filing: $0.0299
Real-time Price: $0.0084 info
Change: -$0.0215 (-72%) info
Market Cap: $713.882K info
Sentiment: Positive
View Wiseek Article
MAJI
Mar 11, 2026, 3:11 PM EDT
Filing Type: 1-A POS
Importance Score:
9
Exousia Pro Amends Offering, Seeks $1.5M at Premium Price Amidst Going Concern Doubts
Price at Filing: $0.02162
Real-time Price: $0.0084 info
Change: -$0.01322 (-61%) info
Market Cap: $713.882K info
Sentiment: Negative
View Wiseek Article
MAJI
Mar 05, 2026, 1:00 PM EST
Source: GlobeNewswire
Importance Score:
9
Exousia Pro Cancels 47M Dilutive Shares, Projects Significant Revenue from Telehealth Acquisitions
Price at Filing: $0.03148
Real-time Price: $0.0084 info
Change: -$0.02308 (-73%) info
Market Cap: $713.882K info
Sentiment: Positive
View Wiseek Article
MAJI
Feb 19, 2026, 4:39 PM EST
Filing Type: 1-A POS
Importance Score:
10
Massive Dilutive Offering at Deep Discount Amidst Going Concern Doubts
Price at Filing: $0.041
Real-time Price: $0.0084 info
Change: -$0.0326 (-80%) info
Market Cap: $713.882K info
Sentiment: Negative
View Wiseek Article
MAJI
Jan 14, 2026, 4:54 PM EST
Filing Type: 253G1
Importance Score:
9
Exousia Pro Amends Offering Circular for Highly Dilutive Capital Raise and Shareholder Sales at Discount Amidst Going Concern Doubts
Price at Filing: $0.0649
Real-time Price: $0.0084 info
Change: -$0.0565 (-87%) info
Market Cap: $713.882K info
Sentiment: Negative
View Wiseek Article